Vincristine
Drug timelines are a Plus or Pro feature.
225 regulatory and trial events tracked for Vincristine, covering 2006-12-14 to 2026-04-23. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010) [Phase 3]